US 9540449
Anti-PCSK9 antibodies with pH-dependent binding characteristics
granted A61KA61K2039/505A61P
Quick answer
US patent 9540449 (Anti-PCSK9 antibodies with pH-dependent binding characteristics) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P3/06